[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100378163":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":17,"responsibleParty":34,"collaborators":7,"id":37,"slug":38,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":41,"acronym":7,"eligibilityCriteria":42,"healthyVolunteers":39,"sex":43,"minAge":44,"maxAge":7,"enrollmentInfo":45,"targetDuration":48,"studyType":49,"phases":7,"briefSummary":50,"conditions":51,"keywords":7,"overallStatus":19,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"Oslo University Hospital","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Aleksander R Holten, PhD","PRINCIPAL_INVESTIGATOR",[13],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","+4799275784","aleksander.holten@gmail.com",[18],{"facility":5,"status":19,"city":20,"state":7,"zip":7,"country":21,"countryCode":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":29},"RECRUITING","Oslo","Norway","NO",{"type":24,"coordinates":25},"Point",[26,27],10.74609,59.91273,{"lat":27,"lon":26},[30],{"name":31,"role":14,"phone":32,"phoneExt":7,"email":33},"Aleksander R Holten, MD, PhD","+47 99275784","aleksander.rygh.holten@ous-hf.no",{"type":11,"investigatorFullName":35,"investigatorTitle":36,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Aleksander Rygh Holten","Principal Investigator","100378163","sepsis-from-syndrome-to-personalized-care-100378163",false,"NCT04203979","Sepsis: From Syndrome to Personalized Care","Inclusion Criteria:\n\n* admitted to emergency department OUH, Ullevål.\n* managed by the medical rapid response team or the sepsis rapid response team\n\nExclusion Criteria:\n\n* Not given informed consent by patient or next of kin (if patient is not able to)","ALL","18 Years",{"count":46,"type":47},1950,"ESTIMATED","1 Year","OBSERVATIONAL","This is a prospective, observational study designed to examine the performance of biomarkers, molecular biological methods and other analysis in blood from patient with suspected sepsis in the Emergency department, as well as identidying novel sepsis endotypes. Around 1500 patients will be enrolled.",[52,53,54,55],"Sepsis Syndrome","Sepsis","Sepsis, Severe","Septic Shock","2026-03-17",{"date":58,"type":59},"2026-03-19","ACTUAL",{"date":61,"type":59},"2020-01-06",{"date":63,"type":47},"2027-09-30",{"name":5,"class":6},1]